Vanguard Group’s IN8bio INAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $126K | Sell |
60,097
-1,742,859
| -97% | -$3.64M | ﹤0.01% | 4129 |
|
|
2025
Q1 | $299K | Buy |
1,802,956
+379,059
| +27% | +$62.9K | ﹤0.01% | 3992 |
|
|
2024
Q4 | $366K | Hold |
1,423,897
| – | – | ﹤0.01% | 4014 |
|
|
2024
Q3 | $384K | Hold |
1,423,897
| – | – | ﹤0.01% | 4034 |
|
|
2024
Q2 | $1.21M | Hold |
1,423,897
| – | – | ﹤0.01% | 3728 |
|
|
2024
Q1 | $1.68M | Buy |
1,423,897
+1,007,201
| +242% | +$1.19M | ﹤0.01% | 3646 |
|
|
2023
Q4 | $575K | Buy |
416,696
+77,968
| +23% | +$108K | ﹤0.01% | 3990 |
|
|
2023
Q3 | $352K | Buy |
338,728
+51,161
| +18% | +$53.2K | ﹤0.01% | 4153 |
|
|
2023
Q2 | $443K | Buy |
287,567
+77,497
| +37% | +$119K | ﹤0.01% | 4152 |
|
|
2023
Q1 | $273K | Buy |
210,070
+41,414
| +25% | +$53.8K | ﹤0.01% | 4271 |
|
|
2022
Q4 | $390K | Sell |
168,656
-872
| -0.5% | -$2.01K | ﹤0.01% | 4165 |
|
|
2022
Q3 | $342K | Buy |
169,528
+58,833
| +53% | +$119K | ﹤0.01% | 4314 |
|
|
2022
Q2 | $250K | Sell |
110,695
-798
| -0.7% | -$1.8K | ﹤0.01% | 4439 |
|
|
2022
Q1 | $372K | Sell |
111,493
-8,723
| -7% | -$29.1K | ﹤0.01% | 4442 |
|
|
2021
Q4 | $528K | Buy |
120,216
+7,116
| +6% | +$31.3K | ﹤0.01% | 4424 |
|
|
2021
Q3 | $775K | Buy |
+113,100
| New | +$775K | ﹤0.01% | 4299 |
|